A new trading day began on Friday, with ARS Pharmaceuticals Inc (NASDAQ: SPRY) stock price up 12.78% from the previous day of trading, before settling in for the closing price of $6.73. SPRY’s price has ranged from $6.73 to $18.90 over the past 52 weeks.
Meanwhile, its annual earnings per share averaged -2241.67%. With a float of $59.72 million, this company’s outstanding shares have now reached $98.84 million.
ARS Pharmaceuticals Inc (SPRY) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of ARS Pharmaceuticals Inc is 39.58%, while institutional ownership is 64.44%. The most recent insider transaction that took place on Nov 13 ’25, was worth 190,050. In this transaction Chief Operating Officer of this company sold 21,828 shares at a rate of $8.71, taking the stock ownership to the 10,789 shares. Before that another transaction happened on Nov 12 ’25, when Company’s Chief Business Officer sold 166,380 for $8.87, making the entire transaction worth $1,476,147. This insider now owns 0 shares in total.
ARS Pharmaceuticals Inc (SPRY) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.51 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.56 per share during the current fiscal year.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Trading Performance Indicators
Here are ARS Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.29 in one year’s time.
Technical Analysis of ARS Pharmaceuticals Inc (SPRY)
Let’s dig in a bit further. During the last 5-days, its volume was 2.71 million. That was better than the volume of 1.86 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 14.84%.
During the past 100 days, ARS Pharmaceuticals Inc’s (SPRY) raw stochastic average was set at 7.77%, which indicates a significant decrease from 25.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.77 in the past 14 days, which was higher than the 0.70 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $9.43, while its 200-day Moving Average is $12.93. However, in the short run, ARS Pharmaceuticals Inc’s stock first resistance to watch stands at $7.97. Second resistance stands at $8.36. The third major resistance level sits at $9.01. If the price goes on to break the first support level at $6.93, it is likely to go to the next support level at $6.28. The third support level lies at $5.89 if the price breaches the second support level.
ARS Pharmaceuticals Inc (NASDAQ: SPRY) Key Stats
With a market capitalization of 750.26 million, the company has a total of 98,849K Shares Outstanding. Currently, annual sales are 89,150 K while annual income is 8,000 K. The company’s previous quarter sales were 32,500 K while its latest quarter income was -51,150 K.
